s6y
Company name or ticker
Search
Propanc Biopharma, Inc.
D
Exempt (Private) Offering
Filed
Thursday, August 31, 2023
Accession number
0001493152-23-031052
Documents
primary_doc.xml
D
On sec.gov
Filing index
All files
Complete submission text
SGML header